article thumbnail

BioIVT acquires Cypex to boost portfolio  

Drug Discovery World

Provider to the life sciences industry BioIVT has acquired enzymes manufacturer Cypex in a bid to enhance its product portfolio. . This technology enables the expression of human drug-metabolizing enzymes in bacteria, without requiring large modifications to the proteins.? .

article thumbnail

How MedFluid is Targeting Antimicrobial Resistance with its Personalized Infection Screening Tool

XTalks

It identifies bacteria using both genotypic and phenotypic assessments within 1.5 Empirical treatment usually gives two to three antibiotics at the same time to suppress unknown bacteria.”. fAST: Automated Bacteria Identification and Multiple Antibiotics Combination Test.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Combating antimicrobial resistance with a viable alternative to traditional antibiotics

pharmaphorum

In its Strategic Priorities on AMR , the WHO made clear that “unless we act now, common diseases will become untreatable and modern life-saving procedures riskier to perform” as AMR proliferates. “How Not to mention that traditional antibiotics are designed to attack a broad spectrum of bacteria within the host’s body.

article thumbnail

Microscopic innovations in women’s health 

Drug Discovery World

This is likely in part because their byproduct, lactic acid, is known to inhibit pathogenic bacteria 25. And, in the endometrium, a decrease in Lactobacillus may affect embryo attachment and promote the growth of detrimental bacteria. This article will focus on one such area of great unmet need and promise: women’s health.

article thumbnail

Xdemvy Sets a New Standard in Demodex Blepharitis Care with FDA Nod

XTalks

Notably, when tested at concentrations up to 30 μM (18 μg/mL) in vitro — which is around 1,100 times the suggested human ocular dose — lotilaner doesn’t affect mammalian GABA-mediated chloride channels. California-based Tarsus Pharmaceuticals Inc., What Is Demodex Blepharitis? percent were diagnosed with Demodex blepharitis.

article thumbnail

How Nanobodies from Cormac the Llama Could Prevent COVID-19 Infection

XTalks

Owing to their size, they can be grown in bacteria as opposed to larger animal or human cells, making them easier and cheaper to produce. These regions play a crucial role in the detection of antigens on viruses, bacteria and other pathogens. The study was led by neuroscientists Thomas J. “TJ” TJ” Esparza, BS, and David L.

Antibody 105
article thumbnail

Reflecting on ELRIG’s Drug Discovery 2022 

Drug Discovery World

The DDW team spent 4-5 October, 2022 at ELRIG’s annual meeting, Drug Discovery 2022, which remains Europe’s largest meeting for life sciences industry professionals and took place at ExCel, London, UK. Over the two days at ExCel, 1554 delegates attended the event. Of those delegates, 75% work in drug discovery.

Drugs 52